Henry F. McFarland, MD

Affiliations: 
NINDS / Neuroimmunology Branch National Institutes of Health, Bethesda, MD 
Area:
multiple sclerosis, neuroimmunology,MR imaging
Google:
"Henry McFarland"
Mean distance: 20.48 (cluster 46)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Borges IT, Shea CD, Ohayon J, et al. (2013) The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 2: 133-140
Yuen TJ, Johnson KR, Miron VE, et al. (2013) Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain : a Journal of Neurology. 136: 1035-47
Ohayon J, Oh U, Richert N, et al. (2013) CNS vasculitis in a patient with MS on daclizumab monotherapy. Neurology. 80: 453-7
Quandt JA, Huh J, Baig M, et al. (2012) Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 189: 2897-908
Bielekova B, McFarland H. (2012) Comment on "interleukin-2/Interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation" Annals of Neurology. 71: 148-149
Bielekova B, Richert N, Herman ML, et al. (2011) Intrathecal effects of daclizumab treatment of multiple sclerosis Neurology. 77: 1877-1886
McFarland H. (2011) The importance of clinical trials in unraveling the mysteries of multiple sclerosis Journal of Neuroimmunology. 231: 3-6
Bomboi G, Ikonomidou VN, Pellegrini S, et al. (2011) Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 21: e57-63
Reingold SC, McFarland HF, John Petkau A. (2011) The growing need for alternative clinical trial designs for multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 253-260
Bagnato F, Salman Z, Kane R, et al. (2010) T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1203-12
See more...